Mesoblast (MESO) Income from Continuing Operations (2015 - 2023)

Mesoblast's (MESO) quarterly Income from Continuing Operations came in at 21959000.0 in Q2 2023, down 0.57% year-on-year from 22084416.42 in Q2 2022, and down 17.77% quarter-over-quarter from 18646000.0 in Q1 2023.

Mesoblast (MESO) Income from Continuing Operations (2015 - 2023) Analysis & Trends

Mesoblast has disclosed Income from Continuing Operations across 9 years of filings, most recently posting 21959000.0 for Q2 2023.

  • Income from Continuing Operations for Q2 2023 came in at 21959000.0, down 0.57% year-over-year; the trailing twelve-month figure through Jun 2023 was 82172000.0 (up 10.69% YoY), and the FY2025 annual result was 102142000.0, down 16.13% from the prior year.
  • Income from Continuing Operations came in at 21959000.0 for Q2 2023 at Mesoblast, down from 18646000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 7416000.0 in Q3 2019 to a low of 29380000.0 in Q1 2019.
  • The 5-year median for Income from Continuing Operations is 22364000.0 (2021), against an average of 22525055.56.
  • Across the five-year window, Income from Continuing Operations soared 64.55% in 2019 and slumped 250.65% in 2020, its largest moves.
  • Mesoblast's Income from Continuing Operations stood at 29122000.0 in 2019, then increased by 12.29% to 25544000.0 in 2020, then declined by 2.2% to 26105000.0 in 2021, then advanced by 5.66% to 24628000.0 in 2022, then climbed by 10.84% to 21959000.0 in 2023.
  • The last three Income from Continuing Operations figures came in at 21959000.0 (Q2 2023), 18646000.0 (Q1 2023), and 24628000.0 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -21.96 Mn
Mar 31, 2023 -18.65 Mn
Dec 31, 2022 -24.63 Mn
Sep 30, 2022 -16.94 Mn
Jun 30, 2022 -21.84 Mn
Mar 31, 2022 -21.29 Mn
Dec 31, 2021 -26.11 Mn
Sep 30, 2021 -22.77 Mn
Jun 30, 2021 -20.55 Mn
Mar 31, 2021 -26.71 Mn
Dec 31, 2020 -25.54 Mn
Sep 30, 2020 -26.00 Mn
Jun 30, 2020 -20.29 Mn
Mar 31, 2020 -19.17 Mn
Dec 31, 2019 -29.12 Mn
Sep 30, 2019 -7.42 Mn
Jun 30, 2019 -27.08 Mn
Mar 31, 2019 -29.38 Mn
Dec 31, 2018 -30.33 Mn
Sep 30, 2018 -20.92 Mn